SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. )
| Filed by the Registrant ☒ | Filed by a Party other than the Registrant ☐ | ||||
| Check the appropriate box: | |||||
| ☐ Preliminary Proxy Statement | |||||
| ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |||||
| ☐ Definitive Proxy Statement | |||||
| ☒ Definitive Additional Materials | |||||
| ☐ Soliciting Material under 240.14a-12 | |||||
BELLICUM PHARMACEUTICALS, INC.
| (Name of Registrant as Specified In Its Charter) | ||||||||||||||
| (Name of Person(s) Filing Proxy Statement if Other Than the Registrant) | ||||||||||||||
| Payment of Filing Fee (check the appropriate box): | |||||
| ☒ No fee required. | |||||
| ☐ Fee paid previously with preliminary materials. | |||||
| ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||||
